Dieta w przewlekłych enteropatiach u kotów

Piśmiennictwo

1. Alexeev E.E. et al.: Microbiota-derived indole metabolites promote human and murine intestinal homeostasis through regulation of interleukin-10 receptor. „Am J Pathol”, 2018, 188, 11831194. DOI: https://doi.org/10.1016/j.ajpath.2018.01.011.
2. Barrs V.R., Beatty J.A.: Feline alimentary lymphoma 2. Further diagnostics, therapy and prognosis. „Journal of Feline Medicine and Surgery”, 2012a, 14, 191-201.
3. Barrs V.R., Beatty J.A.: Feline alimentary lymphoma: 1. Classification, risk factors, clinical signs and non-invasive diagnostics. „Journal of Feline Medicine and Surgery”, 2012b, 14, 182-190.
4. De Souza H.S., Fiocchi C.: Immunopathogenesis of IBD: current state of the art. „Nature Reviews Gastroenterology & Hepatology”, 2016, 13, 13-27.
5. De Souza H.S.P., Fiocchi C., Iliopoulos D.: The IBD interactome: an integrated view of aetiology, pathogenesis and therapy. „Nature Reviews. Gastroenterology & Hepatology”, 2017, 14, 739-749.
6. Golder C., Weemhoff J.L., Jewell D.E.: Cats Have Increased Protein Digestibility as Compared to Dogs and Improve Their Ability to Absorb Protein as Dietary Protein Intake Shifts from Animal to Plant Sources. „Animals”, 2020, 10, 541. DOI: 10.3390/ani10030541.
7. Hisamatsu T., Okamoto S., Hashimoto M. et al.: Novel, Objective, Multivariate Biomarkers Composed of Plasma Amino Acid Profiles for the Diagnosis and Assessment of Inflammatory Bowel Disease. „PLOS ONE”, 2012. DOI: 10.1371/journal.pone.0031131
8. Jergens A.E. Feline idiopathic inflammatory bowel disease: what we know and what remains to be unraveled. „J Feline Med Surg”, 2012, 14 (7), 445-58.
9. Jergens A.E., Crandell J.M., Evans R. et al.: A clinical index for disease activity in cats with chronic enteropathy. „Journal of Veterinary Internal Medicine”, 2010, 24, 1027-1033.
10. Jergens A.E., Moore F.M., Haynes J.S. et al.: Idiopathic inflammatory bowel disease in dogs and cats: 84 cases (1987-1990). „Journal of the American Veterinary Medical Association”, 1992, 201, 1603-1608.
11. Kathrani A., Fascetti A.J., Larsen J.A., Maunder C., Hall E.J.: Whole-Blood Taurine Concentrations in Cats With Intestinal Disease. „Journal of Veterinary Internal Medicine”, 2017, 31, 961-1362. DOI: 10.1111/jvim.14773.
12. Kathrani A., Yen S., Swann J.R., Hall E.J.: The effect of a hydrolyzed protein diet on the fecal microbiota in cats with chronic enteropathy. „Scientific Reports”, 2022, 12, 2746. DOI: https://doi.org/10.1038/s41598-022-06576-y.
13. Kerr K.R., Vester Boler B.M., Morris C.L., Liu K.J., Swanson K.S.: Apparent total tract energy and macronutrient digestibility and fecal fermentative end-product concentrations of domestic cats fed extruded, raw beef-based, and cooked beef-based diets. „J Anim Sci”, 2012. DOI: 90:515-522. doi:10.2527/jas.2010-3266.
14. Kim C.J. et al.: l-Tryptophan exhibits therapeutic function in a porcine model of dextran sodium sulfate (DSS)-induced colitis. „J Nutr Biochem”, 2010, 21, 468-475. DOI: https://doi.org/10.1016/j.jnutbio.2009.01.019.
15. Kunachowicz H., Przygoda B., Nadolna I., Iwanow K.: Tabele składu i wartości odżywczej żywności. Wyd. Lek. PZWL (Wyd. II zmienione), Warszawa 2017.
16. Laflamme D.P., Xu H., Cupp C.J. et al.: Evaluation of canned therapeutic diets for the management of cats with naturally occurring chronic diarrhea. „J Feline Med Surg”, 2012, 14, 669-6.
17. Laflamme D.P., Xu H., Long G.M.: Effect of diets differing in fat content on chronic diarrhea in cats. „J Vet Intern Med”, 2011, 25, 230-23.
18. Lewis L.D., Boulay J.P., Chow F.H.C.: Fat excretion and assimilation by the cat. „Feline Pract”, 1979, 9, 46-49.
19. Makielski K., Cullen J., O’Connor A., Jergens A.E.: Narrative review of therapies for chronic enteropathies in dogs and cats. „J Vet Intern Med”, 2019, 33, 11-22.
20. Mandigers P.J., Biourge V., German A.J.: Efficacy of a commercial hydrolysate diet in eight cats suffering from inflammatory bowel disease or adverse reaction to food. „Tijdschr Diergeneeskd”, 2010, 135, 668-672.
21. Marsilio S., Chow B., Hill S.L., Ackermann M.R. et al.: Untargeted metabolomic analysis in cats with naturally occurring inflammatory bowel disease and alimentary small cell lymphoma. „Scientific Reports”, 2021, 11, 9198. DOI: https://doi.org/10.1038/s41598-021-88707-5.
22. Rozporządzenie Komisji (UE) 2020/354 z dnia 4 marca 2020 r.
23. Sakai K., Maeda S., Yonezawa T., Matsuki N.: Decreased plasma amino acid concentrations in cats with chronic gastrointestinal diseases and their possible contribution in the inflammatory response. „Veterinary Immunology and Immunopathology”, 2018, 195, 1-6. DOI: https://doi.org/10.1016/j.vetimm.2017.11.001).
24. Simpson K.W., Jergens A.E.: Pitfalls and progress in the diagnosis and management of canine inflammatory bowel disease. „The Veterinary Clinics of North America. Small Animal Practice”, 2011, 41, 381-398.
25. Sung C.H., Marsilio S., Chow B., Zornow K.A., Slovak J.E., Pilla R., Lidbury J.A., Steiner J.M., Park S.Y., Hong M.P., Hill S.L., Suchodolski J.S.: Dysbiosis index to evaluate the fecal microbiota in healthy cats and cats with chronic enteropathies. „J Feline Med Surg”, 2022, 24 (6), e1-e12.
26. Waly N.E., Biourge V., Day M.J. et al.: Use of a hydrolysed soya isolate-based diet in the management of chronic idiopathic inflammatory bowel disease and dietary hypersensitivity in cats. „Assiut Vet Med J”, 2010, 56, 158-169.

dr n. wet. Agnieszka Kurosad*
dr n. wet. Sybilla Berwid-Wójtowicz**
* konsultant ds. żywienia zwierząt
VET EXPERT
** kierownik komunikacji naukowej Nestle Purina PetCare Polska
www.dietoprofilaktyka.pl